propensity score-matched cohort. J Thorac Cardiovasc Surg. 2019 Jan;157(1):306-315.e3. \[[PubMed: 30279000](https://pubmed.ncbi.nlm.nih.gov/30279000)\] 10. Kimmelstiel C, Zisa DC, Kuttab JS, Wells S, Udelson JE, Wessler BS, Rastegar H, Kapur NK, Weintraub AR, Maron BJ, Maron MS, Rowin EJ. Guideline-Based Referral for Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Is Associated With Excellent Clinical Outcomes. Circ Cardiovasc Interv. 2019 Jul;12(7):e007673. \[[PMC free article: PMC8018702](/pmc/articles/PMC8018702/)\] \[[PubMed: 31296080](https://pubmed.ncbi.nlm.nih.gov/31296080)\] 11. Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2020 Dec 22;76(25):3022-3055. \[[PubMed: 33229115](https://pubmed.ncbi.nlm.nih.gov/33229115)\] **Disclosure:** Ranjan Dahal declares no relevant financial relationships with ineligible companies. **Disclosure:** Tariq Siddiqui declares no relevant financial relationships with ineligible companies. **Disclosure:** Ghufran Adnan declares no relevant financial relationships with ineligible companies.